192 related articles for article (PubMed ID: 38143259)
1. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
Hum Cell; 2024 Mar; 37(2):511-522. PubMed ID: 38143259
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei.
Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207746
[TBL] [Abstract][Full Text] [Related]
3. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.
Munoz-Zuluaga CA; King MC; Ledakis P; Gushchin V; Sittig M; Nieroda C; Zambrano-Vera K; Sardi A
Eur J Surg Oncol; 2019 Sep; 45(9):1598-1606. PubMed ID: 31109821
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
5. Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC.
Munoz-Zuluaga C; King MC; Sardi A; Ledakis P; Sittig M; Nieroda C; MacDonald R; Gushchin V
Ann Surg Oncol; 2019 Jul; 26(7):2268-2275. PubMed ID: 31041628
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Munoz-Zuluaga C; Sardi A; King MC; Nieroda C; Sittig M; MacDonald R; Gushchin V
Ann Surg Oncol; 2019 Feb; 26(2):473-481. PubMed ID: 30523470
[TBL] [Abstract][Full Text] [Related]
7. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.
Yan F; Lin Y; Zhou Q; Chang H; Li Y
Hum Pathol; 2020 Mar; 97():9-18. PubMed ID: 31926211
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of patient derived xenograft model of high-grade mucinous carcinoma peritonei accompanied with signet ring cells and identification of biological characteristics].
Lin YL; Zhang J; Yang ZR; Li XB; Ji ZH; Xu HB; Yan FC; Zhou Q; Peng Z; Li Y
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):923-931. PubMed ID: 31874550
[No Abstract] [Full Text] [Related]
9. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
11. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei.
Sørensen O; Andersen AM; Larsen SG; Giercksky KE; Flatmark K
Clin Exp Metastasis; 2019 Dec; 36(6):511-518. PubMed ID: 31541325
[TBL] [Abstract][Full Text] [Related]
13. Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review.
Martín-Román L; Hannan E; Faraz Khan M; Müller AS; Shields C; Aird J; Moran B; Mulsow J
Pleura Peritoneum; 2023 Jun; 8(2):65-74. PubMed ID: 37304162
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the presence of epithelial cell clusters in the ascites of patients with pseudomyxoma peritonei.
Ishida M; Mizumoto A; Yonemura Y; Kashu I; Takemura S; Tsuta K
Diagn Cytopathol; 2019 Oct; 47(10):1024-1027. PubMed ID: 31218847
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract][Full Text] [Related]
16. [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
Belhamidi MS; Zorkani Y; Krimou H; Kaoukabi A; Menfaa M; Sakit F; Choho K
Pan Afr Med J; 2019; 33():283. PubMed ID: 31692896
[TBL] [Abstract][Full Text] [Related]
17. Pseudomyxoma Peritonei.
Bartoška P; Antoš F; Vítek P; Marx J; Kopic J; Holečková P
Klin Onkol; 2019; 32(5):329-332. PubMed ID: 31610663
[TBL] [Abstract][Full Text] [Related]
18. Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil.
Lin YL; Zhang J; Yan FC; Jiang X; Ma R; Yang ZR; Xu HB; Peng Z; Chen Q; Li Y
Cancer Med; 2020 Feb; 9(3):1104-1114. PubMed ID: 31814323
[TBL] [Abstract][Full Text] [Related]
19. [Pseudomyxoma Peritonei Caused by Intraductal Papillary Mucinous Neoplasm-A Three Case Series].
Imagami T; Mitsunaka A; Takao N; Mizumoto A; Yonemura Y
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1516-1518. PubMed ID: 38303326
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]